Xenter raises $58.25 million in Series B and adds Linda Vega to board

The funding is aimed at XenFi commercialization, manufacturing expansion, and clinical and regulatory work, including planned testing of the Guru dual sensor physiology guidewire in TAVR procedures.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.